Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Third party research

Medicover: ABGSC Investor Days feedback - ABG

Medicover

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
New CEO is continuing on the strong trajectory
We expect 15% yearly organic growth for '25e-'27e
Trades at ~13x '25e EV/EBITDA


New CEO is not so new

Today, we welcomed Medicover’s new CEO, Mr John Stubbington, to ABGSC’s Investor Days. This was one of Mr Stubbington's first public appearances as CEO, although he has been with the company since 2010, serving as COO of Healthcare Services, a division that accounts for around 70% of the company’s revenues. During his presentation, Mr Stubbington outlined the business model and the main factors driving growth, emphasising the benefits of being a full-service provider of healthcare and related services, particularly in Poland. He also highlighted the synergies from Medicover’s recent acquisitions, both of which are EPS accretive following consolidation.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.